 |
PDBsum entry 6be4
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
6be4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Biol Chem
293:5079-5089
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine.
|
|
C.Soliman,
A.K.Walduck,
E.Yuriev,
J.S.Richards,
C.Cywes-Bentley,
G.B.Pier,
P.A.Ramsland.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In response to the widespread emergence of antibiotic-resistant microbes, new
therapeutic agents are required for many human pathogens. A non-mammalian
polysaccharide, poly-N-acetyl-d-glucosamine (PNAG), is produced by
bacteria, fungi, and protozoan parasites. Antibodies that bind to PNAG and its
deacetylated form (dPNAG) exhibit promising in vitro and in vivo
activities against many microbes. A human IgG1 mAb (F598) that binds both PNAG
and dPNAG has opsonic and protective activities against multiple microbial
pathogens and is undergoing preclinical and clinical assessments as a
broad-spectrum antimicrobial therapy. Here, to understand how F598 targets PNAG,
we determined crystal structures of the unliganded F598 antigen-binding fragment
(Fab) and its complexes with N-acetyl-d-glucosamine (GlcNAc) and a PNAG
oligosaccharide. We found that F598 recognizes PNAG through a large
groove-shaped binding site that traverses the entire light- and heavy-chain
interface and accommodates at least five GlcNAc residues. The Fab-GlcNAc complex
revealed a deep binding pocket in which the monosaccharide and a core GlcNAc of
the oligosaccharide were almost identically positioned, suggesting an anchored
binding mechanism of PNAG by F598. The Fab used in our structural analyses
retained binding to PNAG on the surface of an antibiotic-resistant,
biofilm-forming strain of Staphylococcus aureus Additionally, a model of
intact F598 binding to two pentasaccharide epitopes indicates that the Fab arms
can span at least 40 GlcNAc residues on an extended PNAG chain. Our findings
unravel the structural basis for F598 binding to PNAG on microbial surfaces and
biofilms.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|